Association between self-report adherence measures and oestrogen suppression among breast cancer survivors on aromatase inhibitors

A single-item monthly-recall adherence measure for AIs was associated with oestrogen serum levels. This suggests that patient-reported monthly adherence may be a useful measure to identify early non-adherence behaviour and guide interventions to improve patient adherence to hormonal treatment.